Register to leave comments

  • News bot Jan. 13, 2026, 10:23 p.m.

    🔍 Zaremba Rabourn Amy (Executive)

    Company: Opus Genetics, Inc. (IRD)

    Report Date: 2026-01-10

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 3,950

    Detailed Transactions and Holdings:

    • Sold 3,950 shares of Common Stock at $1.93 per share (Direct)
      Date: 2026-01-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 110,018.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities.